Daavlin

Blog & News

← Older posts

Clinical Phototherapy Provides Significant Revenue for the Practice

Posted on: May 26, 2017

Why is Phototherapy Important? It is estimated that the annual cost of treating psoriasis in the United States is in excess of $11.25 billion dollars.  This is due largely to the high cost of biologic therapies, which can reach $30,000 … Continue reading

UV Light Concerns with Respect to Essential Oils & Diet

Posted on: May 26, 2017

Essential oils are all the rage these days. People are diffusing them to relax as well as applying topical oils to their skin; some of them can have a photosensitizing effect.   Consequently, people are using them and then going out … Continue reading

Why Phototherapy is so Important to Dermatology

Posted on: May 26, 2017

“Of the wide range of treatment modalities available to dermatologists, few possess the history, efficacy, and safety of phototherapy,” said Henry Lim, MD, former chair of the Department of Dermatology at Henry Ford Hospital and current President of the American … Continue reading

Daavlin’s newest innovation….ClearLink!

Posted on: April 25, 2017

Prescribing home phototherapy can seem like a daunting task.  First, there is the prescription, then, for insurance approval, you must provide documentation establishing medical necessity.  In addition, many insurance companies now require chart notes, and don’t forget the long list … Continue reading

Trending at Daavlin: Convenience and Portability

Posted on: April 25, 2017

We love to share with our customers when we see trends in phototherapy, and the recent increase in prescriptions for portable home units is definitely newsworthy! The DermaPal One of the hottest moving products this spring has been the DermaPal, … Continue reading

Patient Adherence, Daily Routines, & Home Phototherapy

Posted on: April 25, 2017

One of the few things that the entire healthcare ecosystem seems to agree on is that patient compliance to therapy is an important goal.  Healthcare providers want to encourage compliance to improve outcomes, and, in the case of certain classes … Continue reading

Our March Dermatology Conferences

Posted on: March 21, 2017

It has been a busy and exciting time for Daavlin!  We have recently attended the Winter AAD meeting, the DNA conference and Phototherapy Workshop, the ADAM meeting and the Photomedicine Society meeting and sessions!  Here are some of the things you missed … Continue reading

Relapse Indicators & the Maintenance Dilemma

Posted on: March 21, 2017

One of the most challenging practical aspects of an initial course of Narrowband UVB phototherapy for psoriasis treatment is uncertainty as to how long, if at all, to expect a patient will be able to go without treatment following a course … Continue reading

Rising Prescription Prices and Patient Impact

Posted on: March 21, 2017

If you have been shocked by the ongoing increases in prescription prices, you are not alone. There are frequent discussions in the news about the rising cost of prescriptions. The debate continues about how to make sure health care resources … Continue reading

Superior UVA1 for Sclerotic Skin Conditions

Posted on: January 27, 2017

For patients with Sclerotic skin conditions (Scleroderma) and severe dermatitis (atopic, dyshidrotic), UVA1 light therapy is an excellent treatment option. UVA1 is a longer wavelength UVA light, running from 340nm to 400nm, and its effects are quite different from UVA2 … Continue reading

← Older posts